United Therapeutics
UTHR
545.00
+3.38
+0.62%
United Therapeutics
US · UTHR
#836 by market cap
Listed 1970
545.00
+3.38
+0.62%
Live - 5344 symbols - heartbeat 210s ago
· 2026-10-08 06:19
Pre-market
546.17
+0.21%
After-hours
545.00
0.00%
Overnight
546.00
+0.18%
- Market cap
- 23.38B
- P/E (TTM)i
- 19.53
- P/Bi
- 3.65
- EPSi
- 27.86
- Div yieldi
- 0.00%
- 52W posi
- 68%
Reader sentiment
Are you bullish or bearish on UTHR?
Anonymous reader poll. Unscientific, not investment advice.
About United Therapeutics
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
- Founded
- 1996
- CEO
- Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD
- Employees
- 1,400
- Headquarters
- Silver Spring, Maryland, United States of America
- Fiscal year end
- 12-31
- Website
- unither.com
Company profile
- Exchange
- US
- Symbol
- UTHR
- Market-cap rank
- #836
- Listing date
- 1970-01-01
- Market cap
- 23.38B
- Float cap
- 21.37B
- Shares out
- 42.89M
- Float shares
- 39.21M
Sectors & themes
Drug Manufacturers - Specialty & Generic
Fractional Shares JP
Quote time 2026-10-08 06:19:20 · For reference only, not investment advice and not tailored to your situation.